STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLPT
  4. [Form 4] ClearPoint Neuro, Inc. Insider Trading Activity

Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

FLETCHER R JOHN reported acquisition or exercise transactions in this Form 4 filing.

ClearPoint Neuro, Inc. director R John Fletcher received a grant of 12,820 restricted stock units as equity compensation. Each unit represents a contingent right to one share of CLPT common stock. The units vest on the earlier of the first anniversary of the grant date or the day immediately before the company’s 2027 annual meeting of stockholders. Following this award, Fletcher holds 12,820 RSUs directly.

Positive

  • None.

Negative

  • None.
Insider FLETCHER R JOHN
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Units 12,820 $0.00 --
Holdings After Transaction: Restricted Stock Units — 12,820 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.
RSUs granted 12,820 units Restricted stock unit award to director on May 21, 2026
Grant price per RSU $0.00 per unit Equity compensation award, no cash paid by insider
Underlying common shares 12,820 shares Each RSU represents one share of CLPT common stock
RSUs held after grant 12,820 units Total restricted stock units directly owned post-transaction
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."
vest financial
"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"The restricted stock units vest on the earlier of ... the day immediately preceding the Company's 2027 annual meeting of stockholders."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FLETCHER R JOHN
(Last)(First)(Middle)
C/O CLEARPOINT NEURO, INC.
120 S. SIERRA AVE., SUITE 100
(Street)
SOLANA BEACH CALIFORNIA 92075
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/21/2026A12,820 (2) (2)Common Stock12,820$012,820D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.
/s/ Danilo D'Alessandro, by Power of Attorney for R. John Fletcher05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ClearPoint Neuro (CLPT) report for R John Fletcher?

ClearPoint Neuro reported that director R John Fletcher received a grant of 12,820 restricted stock units as equity compensation. These units are not a market purchase or sale but an award from the company tied to future vesting conditions.

How many restricted stock units did the ClearPoint Neuro director receive?

R John Fletcher received 12,820 restricted stock units from ClearPoint Neuro. Each unit represents a contingent right to one share of CLPT common stock, subject to vesting conditions based on time and the timing of the company’s 2027 annual meeting of stockholders.

When do the new ClearPoint Neuro RSUs granted to R John Fletcher vest?

The restricted stock units vest on the earlier of the first anniversary of the grant date or the day immediately preceding ClearPoint Neuro’s 2027 annual meeting of stockholders. This time-based vesting schedule ties Fletcher’s equity award to continued board service over the period.

Is the ClearPoint Neuro Form 4 transaction a stock purchase or sale?

The Form 4 reports a grant of restricted stock units, not an open-market purchase or sale. Fletcher acquired 12,820 RSUs as compensation at a price of $0.00 per unit, reflecting an award rather than a cash transaction in the company’s common stock.

How many ClearPoint Neuro RSUs does R John Fletcher hold after this grant?

After this grant, R John Fletcher holds 12,820 restricted stock units directly. These RSUs each represent a contingent right to receive one share of ClearPoint Neuro common stock, subject to the specified vesting schedule tied to time and the 2027 annual meeting.